Trial Profile
Vigabatrin for Treatment of Cocaine Dependence: A Phase II Study
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 25 Feb 2016
Price :
$35
*
At a glance
- Drugs Vigabatrin (Primary)
- Indications Drug dependence
- Focus Therapeutic Use
- Sponsors Catalyst Pharmaceuticals
- 19 Feb 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 14 Oct 2014 New trial record